Enzo Biochem launches SMN immunoassay

Enzo Biochem’s (MYSE:ENZ) Life Sciences arm has launched a unique immunoassay (ELISA) system, which can be used for the identification and detection of survival motor neuron (SMN) protein. The kit is the result of a collaborative agreement between Enzo and the Spinal Muscular Atrophy Foundation for the development of reagents and assays for SMN protein. [...]

Miraculins develops new assay in preeclampsia program

Miraculins (TSX-V:MOM) has developed an ultrasensitive assay for the detection of soluble endoglin, optimized for serum and urine, in an ELISA format as part of its preeclampsia program.  Endoglin is the lead biomarker in its preeclampsia portfolio. “Our initial focus will be to offer this assay to investigators as a research-use-only kit to support preeclampsia [...]